Synthesis, biological evaluation and computational studies of novel iminothiazolidinone benzenesulfonamides as potent carbonic anhydrase II and IX inhibitors

被引：28
|
作者：
Mahmood, Shams-ul [1 ]
Saeed, Aamer [1 ]
Bua, Sivia [2 ]
Nocentini, Alessio [2 ,3 ,4 ]
Gratteri, Paola [3 ,4 ]
Supuran, Claudiu T. [2 ]
机构：
[1] Quaid I Azam Univ, Dept Chem, Islamabad 45320, Pakistan
[2] Univ Florence, Dept NEUROFARBA, Pharmaceut & Nutraceut Sect, Via Ugo Schiff 6, I-50019 Florence, Italy
[3] Univ Florence, Dept NEUROFARBA, Sect Pharmaceut & Nutraceut Sci, Lab Mol Modeling Cheminformat,Pole Sci, Via U Schiff 6, I-50019 Florence, Italy
[4] Univ Florence, QSAR, Polo Sci, Via U Schiff 6, I-50019 Florence, Italy
来源：
BIOORGANIC CHEMISTRY | 2018年 / 77卷
关键词：
Carbonic anhydrase; Zinc-binding group; Nanomolar inhibition; Anti-glaucoma; Anti-tumour; ANTICANCER AGENTS; DESIGN; SULFONAMIDES; MOIETIES; DRUG; DERIVATIVES; ACTIVATORS; DISCOVERY; CANCER; BASES;
D O I：
10.1016/j.bioorg.2018.01.031
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
A series of iminothiazolidinone-sulfonamide hybrids (2a-k) was synthesized by heterocyclization of sulfanilamide thioureas with methyl bromoacetate and characterized by spectroscopic techniques, mass and elemental analysis. The synthesized derivatives were screened against four relevant human (h) isoforms of carbonic anydrases (CAs, EC 4.2.1.1) I, II, IV and IX. These enzymes are involved in a variety of diseases, including glaucoma, retinitis pigmentosa, epilepsy, arthritis, and tumors. Derivatives 2a-2k exhibited the best inhibitory activity against the cytosolyc hCA II (Kis are reaching the sub-nanomolar range, 0.41-37.8 nM) and against the tumor-associated isoform hCA IX (Kis are spanning between 24.3 and 368.3 nM). The binding mode of the reported iminothiazolidinone benzenesulfonamides within hCA II and IX catalytic clefts was investigated by docking studies. (C) 2018 Elsevier Inc. All rights reserved.
引用
收藏
页码：381 / 386
页数：6
相关论文
共 50 条
  • [31] Click-tailed benzenesulfonamides as potent bacterial carbonic anhydrase inhibitors for targeting Mycobacterium tuberculosis and Vibrio cholerae
    Bua, Silvia
    Osman, Sameh M.
    Del Prete, Sonia
    Capasso, Clemente
    AlOthman, Zeid
    Nocentini, Alessio
    Supuran, Claudiu T.
    BIOORGANIC CHEMISTRY, 2019, 86 : 183 - 186
  • [32] New amide derivatives of Probenecid as selective inhibitors of carbonic anhydrase IX and XII: Biological evaluation and molecular modelling studies
    Carradori, Simone
    Mollica, Adriano
    Ceruso, Mariangela
    D'Ascenzio, Melissa
    De Monte, Celeste
    Chimenti, Paola
    Sabia, Rocchina
    Akdemir, Atilla
    Supuran, Claudiu T.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (13) : 2975 - 2981
  • [33] Design, synthesis, biological evaluation and docking analysis of pyrrolidine-benzenesulfonamides as carbonic anhydrase or acetylcholinesterase inhibitors and antimicrobial agents
    Poyraz, Samet
    Dondas, H. Ali
    Yamali, Cem
    Belveren, Samet
    Demir, Yeliz
    Aydinoglu, Sabriye
    Dondas, Naciye Yaktubay
    Taskin-Tok, Tugba
    Tas, Senanur
    Ulger, Mahmut
    Sansano, Jose M.
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2024, 42 (07) : 3441 - 3458
  • [34] Synthesis and Biological Evaluation of Novel Bischalcone Derivatives as Carbonic Anhydrase Inhibitors
    Arslan, Tayfun
    Celik, Gonca
    Celik, Habip
    Senturk, Murat
    Yayli, Nurettin
    Ekinci, Deniz
    ARCHIV DER PHARMAZIE, 2016, 349 (09) : 741 - 748
  • [35] 3-Hydrazinoisatin-based benzenesulfonamides as novel carbonic anhydrase inhibitors endowed with anticancer activity: Synthesis, in vitro biological evaluation and in silico insights
    Abo-Ashour, Mahmoud F.
    Eldehna, Wagdy M.
    Nocentini, Alessio
    Bonardi, Alessandro
    Bua, Silvia
    Ibrahim, Hany S.
    Elaasser, Mahmoud M.
    Krystof, Vladimir
    Jorda, Radek
    Gratteri, Paola
    Abou-Seri, Sahar M.
    Supuran, Claudiu T.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 184
  • [36] Tail approach synthesis of novel benzenesulfonamides incorporating 1,3,4-oxadiazole hybrids as potent inhibitor of carbonic anhydrase I, II, IX, and XII isoenzymes
    Sharma, Vikas
    Kumar, Rajiv
    Angeli, Andrea
    Supuran, Claudiu T.
    Sharma, Pawan K.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 193
  • [37] Synthesis, Biological Evaluation and Molecular Docking Studies of Novel Coumarinylthiazolyl Iminothiazolidinone Hybrids as Potent Urease Inhibitors
    Shams-Ul Mahmood
    Nazir, Yasir
    Saeed, Aamer
    Abbas, Qamar
    Ashraf, Zaman
    CHEMISTRYSELECT, 2020, 5 (18): : 5387 - 5390
  • [38] Novel indolin-2-one-based sulfonamides as carbonic anhydrase inhibitors: Synthesis, in vitro biological evaluation against carbonic anhydrases isoforms I, II, IV and VII and molecular docking studies
    Eldehna, Wagdy M.
    Al-Ansary, Ghada H.
    Bua, Silvia
    Nocentini, Alessio
    Gratteri, Paola
    Altoukhy, Ayman
    Ghabbour, Hazem
    Ahmed, Hanaa Y.
    Supuran, Claudiu T.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 127 : 521 - 530
  • [39] Carbonic anhydrase inhibitors: Synthesis, molecular docking, cytotoxic and inhibition of the human carbonic anhydrase isoforms I, II, IX, XII with novel benzenesulfonamides incorporating pyrrole, pyrrolopyrimidine and fused pyrrolopyrimidine moieties
    Ghorab, Mostafa M.
    Alsaid, Mansour S.
    Ceruso, Mariangela
    Nissan, Yassin M.
    Supuran, Claudiu T.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (14) : 3684 - 3695
  • [40] Chalcone-based benzenesulfonamides as potent and selective inhibitors for human carbonic anhydrase II: Design, synthesis, in vitro, and in silico studies
    Lee, Hwa Young
    Elkamhawy, Ahmed
    Al-Karmalawy, Ahmed A.
    Nada, Hossam
    Giovannuzzi, Simone
    Supuran, Claudiu T.
    Lee, Kyeong
    ARCHIV DER PHARMAZIE, 2024, 357 (11)
12345